Aramis Biotechnologies and the Biologics Manufacturing Centre Announce a Partnership TrendingStockAlerts · Feb 15, 2025
DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development TrendingStockAlerts · Feb 13, 2025
Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025 TrendingStockAlerts · Feb 12, 2025
dsm-firmenich to sell stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion TrendingStockAlerts · Feb 11, 2025
Government of Canada invests $6 million to drive growth in B.C.'s life sciences sector TrendingStockAlerts · Feb 10, 2025
Hospital PMI® at 53.5%; January 2025 Hospital ISM® Report On Business® TrendingStockAlerts · Feb 9, 2025
Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025 TrendingStockAlerts · Feb 8, 2025
Accord Healthcare: Hetronifly® (Serplulimab) receives Marketing Authorisation from the European Commission (EC), for the treatment of Extensive-Stage Small Cell Lung Cancer (ES- SCLC) TrendingStockAlerts · Feb 7, 2025
POLYTECH Health & Aesthetics Strengthens Its Presence in the Nordics TrendingStockAlerts · Feb 6, 2025
Akribion Therapeutics exits from stealth with €8m seed financing to pioneer RNA-guided, programmable cell depletion TrendingStockAlerts · Feb 4, 2025
